D
David Kaufman
Researcher at Simon Fraser University
Publications - 393
Citations - 21380
David Kaufman is an academic researcher from Simon Fraser University. The author has contributed to research in topics: Population & Relative risk. The author has an hindex of 76, co-authored 379 publications receiving 20240 citations. Previous affiliations of David Kaufman include University of Pennsylvania & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Recent Patterns of Medication Use in the Ambulatory Adult Population of the United States: The Slone Survey
TL;DR: In any given week, most US adults take at least 1 medication, and many take multiple agents; the substantial overlap between use of prescription medications and herbals/supplements raises concern about unintended interactions.
Journal ArticleDOI
Applying educational theory in practice
TL;DR: This chapter describes several educational theories and guiding principles and then shows how these could be applied to three case studies realting to the “real world.”
Journal ArticleDOI
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
J.-C. Roujeau,Judith P. Kelly,Luigi Naldi,B. Rzany,Robert S. Stern,Theresa E. Anderson,Ariane Auquier,Sylvie Bastuji-Garin,Osvaldo Correia,F. Locati,Maja Mockenhaupt,C Paoletti,Samuel Shapiro,Neil H. Shear,Erwin Schöpf,David Kaufman +15 more
TL;DR: The use of antibacterial sulfonamides, anticonvulsant agents, oxicam NSAIDs, allopurinol, chlormezanone, and corticosteroids is associated with large increases in the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis, but for none of the drugs does the excess risk exceed five cases per million users per week.
Journal ArticleDOI
Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants
David Kaufman,Robert J. Boyle,Kevin C. Hazen,James T. Patrie,Melinda Robinson,Leigh Goodman Donowitz +5 more
TL;DR: Prophylactic administration of fluconazole during the first six weeks of life is effective in preventing fungal colonization and invasive fungal infection in infants with birth weights of less than 1000 g.
Journal ArticleDOI
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product
Judith P. Kelly,David Kaufman,Jan M. Jurgelon,Jane E. Sheehan,Raymond S. Koff,Samuel Shapiro +5 more
TL;DR: Use of low doses of enteric-coated or buffered aspirin carries a three-fold increase in the risk of major UGIB, suggesting the assumption that these formulations are less harmful than plain aspirin may be mistaken.